Search Results

There are 5103 results for: content related to: Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study)

  1. You have full text access to this OnlineOpen article
    Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA

    The Journal of Clinical Pharmacology

    Volume 57, Issue 4, April 2017, Pages: 459–468, Hisham Abdallah, Joy C. Hsu, Peng Lu, Scott Fettner, Xiaoping Zhang, Wendy Douglass, Min Bao, Lucy Rowell, Gerd R. Burmester and Alan Kivitz

    Version of Record online : 17 NOV 2016, DOI: 10.1002/jcph.826

  2. Tocilizumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Saba Beg and Maria Angeles Lopez-Olivo

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD008331.pub2

  3. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  4. You have free access to this content
    Exposure-Exposure Relationship of Tocilizumab, an Anti–IL-6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 53, Issue 2, February 2013, Pages: 151–159, Micha Levi, Susan Grange and Nicolas Frey

    Version of Record online : 22 FEB 2013, DOI: 10.1177/0091270012437585

  5. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  6. Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Amy S Mudano, Elizabeth Tanjong Ghogomu, Maria E Suarez-Almazor, Rachelle Buchbinder, Lara J Maxwell, Peter Tugwell and George A Wells

    Published Online : 8 MAY 2017, DOI: 10.1002/14651858.CD012657

  7. Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Alomgir Hossain, Elizabeth Tanjong Ghogomu, Amy S Mudano, Lara J Maxwell, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Maria E Suarez-Almazor, Peter Tugwell and George A Wells

    Published Online : 10 MAR 2017, DOI: 10.1002/14651858.CD012591

  8. You have free access to this content
    Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

    Arthritis & Rheumatism

    Volume 63, Issue 3, March 2011, Pages: 609–621, Joel M. Kremer, Ricardo Blanco, Marek Brzosko, Ruben Burgos-Vargas, Anne-Marie Halland, Emma Vernon, Petra Ambs and Roy Fleischmann

    Version of Record online : 25 FEB 2011, DOI: 10.1002/art.30158

  9. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  10. You have full text access to this OnlineOpen article
    Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases

    FEBS Letters

    Volume 585, Issue 23, December 01, 2011, Pages: 3699–3709, Toshio Tanaka, Masashi Narazaki and Tadamitsu Kishimoto

    Version of Record online : 21 MAR 2011, DOI: 10.1016/j.febslet.2011.03.023

  11. Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis

    The Journal of Clinical Pharmacology

    Volume 50, Issue 7, July 2010, Pages: 754–766, Dr Nicolas Frey, Dr Susan Grange and Dr Thasia Woodworth

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009350623

  12. Disease–Drug–Drug Interaction Involving Tocilizumab and Simvastatin in Patients With Rheumatoid Arthritis

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 5, May 2011, Pages: 735–740, C Schmitt, B Kuhn, X Zhang, AJ Kivitz and S Grange

    Version of Record online : 23 MAR 2011, DOI: 10.1038/clpt.2011.35

  13. You have full text access to this OnlineOpen article
    Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis

    Arthritis Care & Research

    Volume 67, Issue 10, October 2015, Pages: 1354–1362, Atsushi Ogata, Tatsuya Atsumi, Takaaki Fukuda, Yasuhiko Hirabayashi, Masaaki Inaba, Naoki Ishiguro, Motokazu Kai, Daisuke Kawabata, Daihei Kida, Hitoshi Kohsaka, Ryutaro Matsumura, Seiji Minota, Masaya Mukai, Takayuki Sumida, Kiyoshi Takasugi, Shigenori Tamaki, Tsutomu Takeuchi, Atsuhisa Ueda, Kazuhiko Yamamoto, Hisashi Yamanaka, Hajime Yoshifuji, Akira Nomura and the Musashi Study Investigators

    Version of Record online : 22 SEP 2015, DOI: 10.1002/acr.22598

  14. You have free access to this content
    Poster Presentation Abstracts

    International Journal of Rheumatic Diseases

    Volume 19, Issue S2, September 2016, Pages: 21–293,

    Version of Record online : 19 SEP 2016, DOI: 10.1111/1756-185X.12962

  15. Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic in a Global Comparative Observational Study

    Arthritis Care & Research

    Accepted manuscript online: 16 JUN 2017, Ernest H. Choy, Corrado Bernasconi, Maher Aassi, Jose Fernando Molina and Oscar Massimiliano Epis

    DOI: 10.1002/acr.23303

  16. Transaminase Levels and Hepatic Events During Tocilizumab Treatment: Pooled Analysis of Long-Term Clinical Trial Safety Data in Rheumatoid Arthritis

    Arthritis & Rheumatology

    Accepted manuscript online: 8 JUN 2017, Mark C. Genovese, Joel M. Kremer, Ronald F. van Vollenhoven, Rieke Alten, Juan Jose Scali, Ariella Kelman, Sophie Dimonaco and Laura Brockwell

    DOI: 10.1002/art.40176

  17. You have free access to this content
    Interleukin-6 blockade in ocular inflammatory diseases

    Clinical & Experimental Immunology

    Volume 176, Issue 3, June 2014, Pages: 301–309, M. Mesquida, A. Leszczynska, V. Llorenç and A. Adán

    Version of Record online : 24 APR 2014, DOI: 10.1111/cei.12295

  18. You have free access to this content
    Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer

    International Journal of Cancer

    Volume 137, Issue 5, 1 September 2015, Pages: 1035–1046, Freya A. Goumas, Reinhild Holmer, Jan-Hendrik Egberts, Artur Gontarewicz, Carola Heneweer, Ulf Geisen, Charlotte Hauser, Maria-Margarete Mende, Karen Legler, Christoph Röcken, Thomas Becker, Georg H. Waetzig, Stefan Rose-John and Holger Kalthoff

    Version of Record online : 29 JAN 2015, DOI: 10.1002/ijc.29445

  19. You have free access to this content
    Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate

    Arthritis & Rheumatism

    Volume 54, Issue 9, September 2006, Pages: 2817–2829, R. N. Maini, P. C. Taylor, J. Szechinski, K. Pavelka, J. Bröll, G. Balint, P. Emery, F. Raemen, J. Petersen, J. Smolen, D. Thomson and T. Kishimoto

    Version of Record online : 31 AUG 2006, DOI: 10.1002/art.22033

  20. You have free access to this content
    Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

    Arthritis & Rheumatism

    Volume 58, Issue 10, October 2008, Pages: 2968–2980, Mark C. Genovese, James D. McKay, Evgeny L. Nasonov, Eduardo F. Mysler, Nilzio A. da Silva, Emma Alecock, Thasia Woodworth and Juan J. Gomez-Reino

    Version of Record online : 29 SEP 2008, DOI: 10.1002/art.23940